Logo image of DTCK

DAVIS COMMODITIES LTD (DTCK) Stock Fundamental Analysis

NASDAQ:DTCK - Nasdaq - KYG2677P1054 - Common Stock - Currency: USD

0.6273  -0.02 (-3.48%)

Fundamental Rating

5

Overall DTCK gets a fundamental rating of 5 out of 10. We evaluated DTCK against 41 industry peers in the Consumer Staples Distribution & Retail industry. DTCK is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DTCK is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year DTCK was profitable.
In the past year DTCK had a positive cash flow from operations.
DTCK Yearly Net Income VS EBIT VS OCF VS FCFDTCK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M 4M

1.2 Ratios

DTCK has a better Return On Assets (8.43%) than 90.24% of its industry peers.
Looking at the Return On Equity, with a value of 20.88%, DTCK is in the better half of the industry, outperforming 78.05% of the companies in the same industry.
The Return On Invested Capital of DTCK (16.41%) is better than 97.56% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DTCK is significantly above the industry average of 7.99%.
The 3 year average ROIC (88.94%) for DTCK is well above the current ROIC(16.41%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 8.43%
ROE 20.88%
ROIC 16.41%
ROA(3y)16.13%
ROA(5y)N/A
ROE(3y)104.73%
ROE(5y)N/A
ROIC(3y)88.94%
ROIC(5y)N/A
DTCK Yearly ROA, ROE, ROICDTCK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 50 100 150 200

1.3 Margins

DTCK has a Profit Margin of 0.94%. This is comparable to the rest of the industry: DTCK outperforms 46.34% of its industry peers.
DTCK's Profit Margin has improved in the last couple of years.
DTCK's Operating Margin of 0.88% is on the low side compared to the rest of the industry. DTCK is outperformed by 65.85% of its industry peers.
DTCK has a worse Gross Margin (3.86%) than 97.56% of its industry peers.
DTCK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.88%
PM (TTM) 0.94%
GM 3.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y14.44%
PM growth 5YN/A
GM growth 3Y-6.32%
GM growth 5YN/A
DTCK Yearly Profit, Operating, Gross MarginsDTCK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 2 4 6

7

2. Health

2.1 Basic Checks

DTCK has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, DTCK has more shares outstanding
The debt/assets ratio for DTCK has been reduced compared to a year ago.
DTCK Yearly Shares OutstandingDTCK Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M
DTCK Yearly Total Debt VS Total AssetsDTCK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 10.42 indicates that DTCK is not in any danger for bankruptcy at the moment.
The Altman-Z score of DTCK (10.42) is better than 97.56% of its industry peers.
The Debt to FCF ratio of DTCK is 0.27, which is an excellent value as it means it would take DTCK, only 0.27 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.27, DTCK belongs to the best of the industry, outperforming 90.24% of the companies in the same industry.
DTCK has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DTCK (0.03) is better than 80.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.27
Altman-Z 10.42
ROIC/WACC1.87
WACC8.79%
DTCK Yearly LT Debt VS Equity VS FCFDTCK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 1.31 indicates that DTCK should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.31, DTCK is in the better half of the industry, outperforming 73.17% of the companies in the same industry.
A Quick Ratio of 0.93 indicates that DTCK may have some problems paying its short term obligations.
DTCK has a better Quick ratio (0.93) than 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.93
DTCK Yearly Current Assets VS Current LiabilitesDTCK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M

3

3. Growth

3.1 Past

The earnings per share for DTCK have decreased strongly by -63.88% in the last year.
DTCK shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.35% yearly.
DTCK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.40%.
Measured over the past years, DTCK shows a quite strong growth in Revenue. The Revenue has been growing by 13.17% on average per year.
EPS 1Y (TTM)-63.88%
EPS 3Y30.35%
EPS 5YN/A
EPS Q2Q%-35.04%
Revenue 1Y (TTM)-15.4%
Revenue growth 3Y13.17%
Revenue growth 5YN/A
Sales Q2Q%-31.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DTCK Yearly Revenue VS EstimatesDTCK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 50M 100M 150M 200M

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.27 indicates a rather cheap valuation of DTCK.
95.12% of the companies in the same industry are more expensive than DTCK, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 24.83, DTCK is valued rather cheaply.
Industry RankSector Rank
PE 6.27
Fwd PE N/A
DTCK Price Earnings VS Forward Price EarningsDTCK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DTCK is valued cheaply inside the industry as 80.49% of the companies are valued more expensively.
92.68% of the companies in the same industry are more expensive than DTCK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.75
EV/EBITDA 6.4
DTCK Per share dataDTCK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DTCK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DAVIS COMMODITIES LTD

NASDAQ:DTCK (5/13/2025, 2:43:05 PM)

0.6273

-0.02 (-3.48%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.46%
Inst Owner ChangeN/A
Ins Owners34.09%
Ins Owner ChangeN/A
Market Cap15.37M
AnalystsN/A
Price TargetN/A
Short Float %0.95%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.27
Fwd PE N/A
P/S 0.06
P/FCF 7.75
P/OCF 7.75
P/B 1.33
P/tB 1.33
EV/EBITDA 6.4
EPS(TTM)0.1
EY15.94%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.08
FCFY12.9%
OCF(TTM)0.08
OCFY12.91%
SpS10.51
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.43%
ROE 20.88%
ROCE 19.13%
ROIC 16.41%
ROICexc 18.53%
ROICexgc 18.53%
OM 0.88%
PM (TTM) 0.94%
GM 3.86%
FCFM 0.77%
ROA(3y)16.13%
ROA(5y)N/A
ROE(3y)104.73%
ROE(5y)N/A
ROIC(3y)88.94%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)103.68%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y14.44%
PM growth 5YN/A
GM growth 3Y-6.32%
GM growth 5YN/A
F-Score3
Asset Turnover8.97
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.27
Debt/EBITDA 0.13
Cap/Depr 2.5%
Cap/Sales 0%
Interest Coverage 36.17
Cash Conversion 84.1%
Profit Quality 81.9%
Current Ratio 1.31
Quick Ratio 0.93
Altman-Z 10.42
F-Score3
WACC8.79%
ROIC/WACC1.87
Cap/Depr(3y)171.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.88%
EPS 3Y30.35%
EPS 5YN/A
EPS Q2Q%-35.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.4%
Revenue growth 3Y13.17%
Revenue growth 5YN/A
Sales Q2Q%-31.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.15%
FCF growth 3Y-19.86%
FCF growth 5YN/A
OCF growth 1Y48.06%
OCF growth 3Y-14.95%
OCF growth 5YN/A